<?xml-stylesheet type="text/xsl" href="https://www.vetnurse.co.uk/utility/feedstylesheets/rss.xsl" media="screen"?><rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:slash="http://purl.org/rss/1.0/modules/slash/" xmlns:wfw="http://wellformedweb.org/CommentAPI/"><channel><title>Bayer launches next-generation fluoroquinilone; first for canine periodontal infections</title><link>/b/veterinary-nursing-news/posts/120836</link><description> Bayer Animal Health has launched a next generation fluoroquinolone antimicrobial - Veraflox (pradofloxacin) - for the treatment of bacterial infections in cats and dogs. 
 Bayer Animal Health&amp;#39;s marketing manager Dr Markus Edingloh said: &amp;quot;Veraflox, with</description><dc:language>en-US</dc:language><generator>Telligent Community 10</generator></channel></rss>